“…Pathogenesis in S. epidermidis is largely under the regulation of quorum sensing (QS), a chemical-based cell–cell communication system, which makes QS an attractive target to potentially attenuate virulence phenotypes in this bacterium. − QS activation can increase S. epidermidis ’ capability for skin colonization, evasion of the host immune system, and tissue infiltration. , In contrast, QS inhibition in S. epidermidis has been shown to allow for more resilient biofilm formation, shielding S. epidermidis from antibiotics and the immune system. ,, Non-native small molecules and peptides capable of either inhibiting or activating QS have been developed in other bacteria and have shown significant value as research tools and as potential antivirulence agents. − While there are merits to either intentionally activating or inhibiting QS to curb S. epidermidis infections, given that the primary mechanism by which S. epidermidis causes device-associated infections is through biofilm formation, ,, this connection suggests that the development of chemical tools to agonize QS and thereby promote biofilm dispersion may provide the most benefit in reducing S. epidermidis growth on surfaces and rendering them more vulnerable to treatment with antibiotics or clearance via the host immune system. , Studies in S. aureus , which utilizes a similar QS system to regulate biofilm formation, have demonstrated that activation of QS through addition of agonists dispersed biofilms, significantly increasing their susceptibility to antibiotics relative to untreated S. aureus biofilms . Identifying such QS agonists to combat S. epidermidis biofilms was a motivation for the current study.…”